No intervention. This is an observational study

OTHER2 trials

Sponsors

Chisquares Incorporated, Charles Kung, associate director Agios Pharmaceuticals

Conditions

Artificial IntelligenceBurnout, ProfessionalCOVID-19Climate ChangeEmerging Infectious DiseaseMental Health IssueOnline EducationPatient Engagement

Unknown Phase

Active, not recruitingNL-OMON24118

Charles Kung, associate director Agios Pharmaceuticalssickle cell anemia, sikkelcelziekte, sikkelcelanemie, sikkel cel, thalassemia, thalassemie, unstable Hb, instabiel hb, haemoglobinopathies, haemoglobinopathie

Start: 2017-09-01Target: 55Updated: 2024-06-11

Collaborative Open Research Initiative Study (CORIS-1)

Not yet recruitingNCT06357650

Chisquares IncorporatedArtificial Intelligence, Burnout, Professional, Climate Change +7

Start: 2024-06-01End: 2025-06-30Target: 15000Updated: 2024-04-10